| Geld/Brief | 23,05 $ / 29,52 $ |
| Spread | +28,07% |
| Schluss Vortag | 26,65 $ |
| Gehandelte Stücke | 58.606 |
| Tagesvolumen Vortag | 671.194,1 $ |
| Tagestief 26,18 $ Tageshoch 27,15 $ | |
| 52W-Tief - 52W-Hoch 27,14 $ | |
| Jahrestief - Jahreshoch 27,14 $ | |
| Umsatz in Mio. | 6,50 $ |
| Operatives Ergebnis (EBIT) in Mio. | -74,68 $ |
| Jahresüberschuss in Mio. | -63,73 $ |
| Umsatz je Aktie | 0,12 $ |
| Gewinn je Aktie | -1,19 $ |
| Gewinnrendite | -980,93% |
| Umsatzrendite | -980,93% |
| Return on Investment | -24,06% |
| Marktkapitalisierung in Mio. | 1.434 $ |
| KGV (Kurs/Gewinn) | - |
| KBV (Kurs/Buchwert) | - |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | -55,17% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 26,90 $ | +2,75% | 26,18 $ | 04.09.26 | |
| Nasdaq | 27,14 $ | +1,84% | 26,65 $ | 04.09.26 | |
| NYSE | 27,08 $ | +2,27% | 26,48 $ | 04.09.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 04.09.26 | 27,05 | 0,67 M |
| 03.09.26 | 26,65 | 349 T |
| 02.09.26 | 26,92 | 0,57 M |
| 01.09.26 | 25,99 | 389 T |
| 31.08.26 | 25,91 | 390 T |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 25,78 $ | +5,28% |
| 1 Monat | 22,84 $ | +18,83% |
| 6 Monate | 20,89 $ | +29,92% |
| 1 Jahr | - | - |
| 5 Jahre | - | - |
| Marktkapitalisierung | 1,43 Mrd. $ |
| Streubesitz | 11,67% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +8,75% | MPM Oncology Impact Management LP |
| +8,73% | EcoR1 Capital, LLC |
| +5,72% | Blue Owl Capital Holdings LP |
| +4,19% | Wellington Management Company LLP |
| +3,84% | T. Rowe Price Investment Management,Inc. |
| +3,82% | BlackRock Inc |
| +3,66% | Vanguard Health Care Inv |
| +2,88% | RTW INVESTMENTS, LLC |
| +2,83% | T. Rowe Price Associates, Inc. |
| +2,72% | RA Capital Management, LLC |
| +2,63% | HHG PLC |
| +1,92% | T. Rowe Price Health Sciences |
| +1,80% | Baker Bros Advisors LP |
| +1,74% | Octagon Capital Advisors LP |
| +1,72% | Merck & Co Inc |
| +1,70% | Avidity Partners Management LP |
| +1,51% | Vanguard Capital Management, LLC |
| +1,25% | TCG Crossover Management, LLC |
| +1,23% | T. Rowe Price US Small-Cap Core Equity |
| +1,22% | T. Rowe Price Small-Cap Stock |
| +1,10% | Vanguard Total Stock Mkt Idx Inv |
| +1,06% | Vanguard Morn Total Stk Mkt Idx Investor |
| +1,05% | Vanguard MStar Total Stk Mkt Idx Invest |
| +0,92% | Eventide Asset Management, LLC |
| +0,92% | Eventide Healthcare & Life Sciences I |
| +0,89% | iShares Russell 2000 ETF |
| +0,89% | Geode Capital Management, LLC |
| +0,77% | State Street Corp |
| +0,70% | FMR Inc |
| +0,67% | BGF World Healthscience A2 |
| +0,65% | T. Rowe Price Instl Small-Cap Stock |
| +0,64% | UBS Group AG |
| +0,58% | T. Rowe Price U.S. SC Core Eq Tr-D |
| +0,51% | Fidelity Select Biotechnology |
| +0,48% | BlackRock Health Sciences Opps Inv A |
| +0,39% | T. Rowe Price US Smlr Coms Eq A |
| +0,38% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,37% | T. Rowe Price Small-Cap Value |
| +0,36% | T. Rowe Price New Horizons |
| +0,36% | Fidelity Small Cap Index |
| +0,36% | US Small-Cap Growth II Equity Comp |
| +0,29% | State St Russell Sm/Mid Cp® Indx SL Cl I |
| +0,26% | Russell 2000 Equity Index Fund B |
| +0,25% | iShares Russell 2000 Growth ETF |
| +0,24% | T. Rowe Price U.S. SC Value Eq Tr-D |
| +74,192% | Institutionelle Aktionäre |
| +14,143% | Insider Aktionäre |
| +11,665% | Streubesitz |
